Nanoemulsion as pharmaceutical carrier for dermal and transdermal drug delivery: Formulation development, stability issues, basic considerations and applications
The use of nanoemulsion in augmenting dermal and transdermal effectiveness of drugs has
now well established. The development of nanoemulsion based semisolid dosage forms is …
now well established. The development of nanoemulsion based semisolid dosage forms is …
Nanoemulsion-based dosage forms for the transdermal drug delivery applications: A review of recent advances
Introduction Nanoemulsion-based drug delivery approaches have witnessed massive
acceptance over the years and acquired a significant foothold owing to their tremendous …
acceptance over the years and acquired a significant foothold owing to their tremendous …
Lipid based nanocarrier system for the potential oral delivery of decitabine: formulation design, characterization, ex vivo, and in vivo assessment
The aim of this study was to design and fabricate nanostructured lipid carrier (NLC) for the
potential oral delivery of decitabine (DCB). NLC was prepared by cold homogenization …
potential oral delivery of decitabine (DCB). NLC was prepared by cold homogenization …
Lipid-nanopotentiated combinatorial delivery of tamoxifen and sulforaphane: ex vivo, in vivo and toxicity studies
Aim: This study aims to load tamoxifen (TAM) and sulforaphane (SFN) into nanostructured
lipid carriers (NLCs) to enhance their oral delivery. Materials & methods: TAM-SFN-NLCs …
lipid carriers (NLCs) to enhance their oral delivery. Materials & methods: TAM-SFN-NLCs …
Nanostructured lipid carrier potentiated oral delivery of raloxifene for breast cancer treatment
NK Soni, LJ Sonali, A Singh, B Mangla… - …, 2020 - iopscience.iop.org
Nanotherapeutics in cancer treatment are dominating global science and research, and
have been recognized as the pioneering medical care regimen. Raloxifene (RLN) has been …
have been recognized as the pioneering medical care regimen. Raloxifene (RLN) has been …
The optimization design of lactoferrin loaded HupA nanoemulsion for targeted drug transport via intranasal route
Y Jiang, C Liu, W Zhai, N Zhuang, T Han… - International journal of …, 2019 - Taylor & Francis
Background Huperzine A (HupA) is a selective acetylcholinesterase inhibitor used to treat
Alzheimer's disease. The existing dosage of HupA lacks brain selectivity and can cause …
Alzheimer's disease. The existing dosage of HupA lacks brain selectivity and can cause …
[HTML][HTML] Investigation of the “Nose-to-Brain” pathways in intranasal HupA nanoemulsions and evaluation of their in vivo pharmacokinetics and brain-targeting ability
Y Jiang, Y Jiang, Z Ding, Q Yu - International Journal of …, 2022 - ncbi.nlm.nih.gov
Purpose While developing huperzine A (HupA) to explore new approaches to treating
Alzheimer's disease (AD), intranasal administration was proposed as an alternative route to …
Alzheimer's disease (AD), intranasal administration was proposed as an alternative route to …
Facile functionalization of Teriflunomide-loaded nanoliposomes with Chondroitin sulphate for the treatment of Rheumatoid arthritis
This research aims to coat Teriflunomide (TEF) loaded conventional nanoliposomes (CON-
TEF-LIPO) with Chondroitin sulphate (CS) to produce CS-TEF-LIPO for the effective …
TEF-LIPO) with Chondroitin sulphate (CS) to produce CS-TEF-LIPO for the effective …
Formulation of sitagliptin-loaded oral polymeric nano scaffold: process parameters evaluation and enhanced anti-diabetic performance
MA Jahangir, R Khan, S Sarim Imam - Artificial cells, nanomedicine …, 2018 - Taylor & Francis
Purpose The aim of the study to formulate and statistically optimize sitagliptin-loaded
eudragit nanoparticles (SIT-NPs) and evaluate the in-vitro pharmaceutical quality and in …
eudragit nanoparticles (SIT-NPs) and evaluate the in-vitro pharmaceutical quality and in …
Tamoxifen and Sulphoraphane for the breast cancer management: A synergistic nanomedicine approach
Breast cancer is second most leading cause of death in all over the world and not only
limited to the females. Tamoxifen has been considered as the gold line therapy for estrogen …
limited to the females. Tamoxifen has been considered as the gold line therapy for estrogen …